AQS, a biopharmaceutical consulting/dev. company, has been operating in US/Asia, for 10 years, consisting of former MNC biotech scientists. We have identified a big need for reduced price recombinant protein derived blood coagulation drugs, for the developing world, especially Factor VIII. We have developed superior proven technology consisting of high expression levels which leads to dramatically lower mfg. costs per I/U, using a CRO/CMO.